How the availability of recombinant human TSH has changed the management of patients who have thyroid cancer
- 1 September 2007
- journal article
- review article
- Published by Springer Nature in Nature Clinical Practice Endocrinology & Metabolism
- Vol. 3 (9) , 641-650
- https://doi.org/10.1038/ncpendmet0594
Abstract
Recombinant human TSH (rhTSH) is used in patients who have had surgery for thyroid cancer but are at low risk of recurrence. The rhTSH is used for the preparation of postoperative administration of 3.7 GBq (100 mCi) of radioiodine for thyroid-remnant ablation and for the determination of serum thyroglobulin levels during follow-up. In these two conditions, the efficiencies of levothyroxine withdrawal and rhTSH administration are similar; however, rhTSH can be administered during levothyroxine treatment, and its use avoids the hypothyroid period induced by levothyroxine withdrawal, reduces whole body exposure after radioiodine administration, avoids potential morbidity and maintains a better quality of life compared with hormone withdrawal.Keywords
This publication has 36 references indexed in Scilit:
- Defects in iodide metabolism in thyroid cancer and implications for the follow-up and treatment of patientsNature Clinical Practice Endocrinology & Metabolism, 2007
- Short-term hypothyroidism after Levothyroxine-withdrawal in patients with differentiated thyroid cancer: clinical and quality of life consequencesActa Endocrinologica, 2007
- European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epitheliumActa Endocrinologica, 2006
- Radioiodine Ablation of Thyroid Remnants after Preparation with Recombinant Human Thyrotropin in Differentiated Thyroid Carcinoma: Results of an International, Randomized, Controlled StudyJournal of Clinical Endocrinology & Metabolism, 2006
- 123I Thyroid Uptake and Thyroid Size at 24, 48, and 72 Hours after the Administration of Recombinant Human Thyroid-Stimulating Hormone to Normal VolunteersJournal of Clinical Endocrinology & Metabolism, 2006
- Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines TaskforceThyroid®, 2006
- Effect of Various Doses of Recombinant Human Thyrotropin on the Thyroid Radioactive Iodine Uptake and Serum Levels of Thyroid Hormones and Thyroglobulin in Normal SubjectsJournal of Clinical Endocrinology & Metabolism, 2001
- Quality-of-Life Changes in Patients with Thyroid Cancer After Withdrawal of Thyroid Hormone TherapyThyroid®, 1997
- Cloning of the Human Thyrotropin β-Subunit Gene and Transient Expression of Biologically Active Human Thyrotropin after Gene TransfectionMolecular Endocrinology, 1988
- Different rates of thyrotropin suppression after total body scan in patients with thyroid cancer: effect of regular doses of thyroxine and triiodothyronineJournal of Endocrinological Investigation, 1983